BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Intestine
,
Holistic medicine
,
Phenobarbital
,
rs2300478
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukins 16
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Pyroptotic TÂ cell-derived active IL-16 has a driving function in ovarian endometriosis development.
Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro.
Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16…
The Significant Contribution of Interleukin-16 Genotypes, Smoking, Alcohol Drinking, and Helicobacte…
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HIV Reservoir Reduction With Interleukin-2
RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors (HNSCC, Cerv…
Ultra Low Dose Interleukin-2 in Healthy Volunteers
Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria
Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ